beta

ABMD

ABIOMED, Inc.

Abmd

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded in 1981 and is headquartered in Danvers, MA.

Market Cap: 8.21 Billion

Primary Exchange: NASDAQ

Website: http://www.abiomed.com

Shares Outstanding: 45.2 Million

Float: 44.1 Million

Dividend: (%)

Beta: 1.30592764615691

Sector: Health Technology

Industry: Medical Specialties

Ethical Flags

Animal testing

Longest drawdown: 317 trading days

From: 2018-09-28 To: 2019-12-13

Lowest Point:

Impella Featured as an Innovative Technology at U.S. Capitol Event Showcasing Improvements to Women's Health

via: Business Wire at 2019-06-13 10:00:00:000

Abiomeds(NASDAQ:ABMD) Impella platform is being featured today at a Washington, D.C., event showcasing innovations in medical technology that improve healthcare for women. Abiomeds participation supports its Womens Initiative for Heart Recovery , which provid… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud